Show simple item record

dc.contributor.authorMurphy, O.
dc.contributor.authorO'Connell, O.
dc.contributor.authorListon, R.
dc.contributor.authorConnaughton, J.
dc.contributor.authorCostello, R.
dc.contributor.authorBreiden, J.
dc.contributor.authorDoran, P.
dc.contributor.authorGaine, S.
dc.date2022-08-11T08:08:08.000
dc.date.accessioned2022-08-23T15:43:31Z
dc.date.available2022-08-23T15:43:31Z
dc.date.issued2012-05-01
dc.date.submitted2014-12-12
dc.identifier.citationIr Med J. 2012 May;105(5):140-3.
dc.identifier.issn0332-3102 (Linking)
dc.identifier.pmid22803491
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27114
dc.description.abstractENDORSE (Epidemiologic International Day for the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute Hospital Care Setting), is a multinational, cross-sectional survey of venous thromboembolism (VTE) risk prevalence and effective prophylaxis in the acute hospital care setting. Three Irish hospitals enrolled in the study. The American College of Chest Physicians (ACCP) guidelines were employed to evaluate VTE risk and prophylaxis. Of 552 patients, 297 (53.8%) and 255 (46.2%) were categorised as surgical or medical, respectively, with 175 (59%) surgical and 109 (43%) medical patients deemed to be at risk for VTE. Of these, only 112 (64%) and 51 (47%) received recommended VTE prophylaxis, respectively. The results are consistent with those observed in other countries and demonstrate a high prevalence of risk for VTE and a low rate of prophylaxis use, particularly in medical patients. Awareness of VTE guidelines should be an integral component of health policy.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=22803491&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://www.imj.ie//ViewArticleDetails.aspx?ArticleID=9353
dc.subjectAnticoagulants
dc.subjectCross-Sectional Studies
dc.subjectFemale
dc.subjectGuideline Adherence
dc.subjectHospitalization
dc.subjectHumans
dc.subjectIreland
dc.subjectMale
dc.subjectMedical Audit
dc.subjectPhysician's Practice Patterns
dc.subjectPractice Guidelines as Topic
dc.subjectPrevalence
dc.subjectRisk Factors
dc.subjectVenous Thromboembolism
dc.subjectCardiovascular Diseases
dc.subjectClinical Epidemiology
dc.subjectEpidemiology
dc.subjectHealth Services Research
dc.titleVenous thromboembolism risk and prophylaxis in the acute hospital care setting: the Irish results of the ENDORSE study
dc.typeJournal Article
dc.source.journaltitleIrish medical journal
dc.source.volume105
dc.source.issue5
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cor_endorse/15
dc.identifier.contextkey6456543
html.description.abstract<p>ENDORSE (Epidemiologic International Day for the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute Hospital Care Setting), is a multinational, cross-sectional survey of venous thromboembolism (VTE) risk prevalence and effective prophylaxis in the acute hospital care setting. Three Irish hospitals enrolled in the study. The American College of Chest Physicians (ACCP) guidelines were employed to evaluate VTE risk and prophylaxis. Of 552 patients, 297 (53.8%) and 255 (46.2%) were categorised as surgical or medical, respectively, with 175 (59%) surgical and 109 (43%) medical patients deemed to be at risk for VTE. Of these, only 112 (64%) and 51 (47%) received recommended VTE prophylaxis, respectively. The results are consistent with those observed in other countries and demonstrate a high prevalence of risk for VTE and a low rate of prophylaxis use, particularly in medical patients. Awareness of VTE guidelines should be an integral component of health policy.</p>
dc.identifier.submissionpathcor_endorse/15
dc.contributor.departmentCenter for Outcomes Research
dc.source.pages140-3


This item appears in the following Collection(s)

Show simple item record